Basic Science Symposium: Metabolic Landscape and Networks in Hepatobiliary Malignancies, Part 1

Description

This basic science symposium delves into the intricate interplay between metabolism and liver cancer. The program brings together leading experts, researchers, and scientists from various fields to explore cutting-edge developments in the understanding of how metabolic processes impact the development and progression of liver malignancies. The session includes presentations on metabolic reprogramming; metabolic competition between cancer cells and cells of the tumor microenvironment; immunometabolism; metabolic plasticity; and therapeutic opportunities targeting liver cancer metabolism. Growing awareness of the significance and prevalence of these mechanisms is leading to a deeper understanding of their involvement in tumor initiation and advancement. This understanding, in turn, is guiding basic and translational liver cancer research to identify metabolic vulnerabilities of liver cancers that might be exploited as therapeutic strategies.
 

Journey Maps

Presentations

8:00 AM - 8:20 AM
Nov 15 2024
San Diego, CA

Unraveling the Metabolic Landscape of Liver Cancers: Genome Meets Metabolism

Rocio IR Macias, PhD, Presenter
Basic Science
8:20 AM - 8:40 AM
Nov 15 2024
San Diego, CA

Identification of Novel Oncometabolites as Diagnostic and Predictive Biomarkers and Their Role in Hepatocellular Carcinoma Development

Zan Huang, PhD, Presenter
Basic Science
8:40 AM - 9:00 AM
Nov 15 2024
San Diego, CA

Lipid Reprogramming in Hepatocellular Carcinoma and Cholangiocarcinoma

Hayato Nakagawa, MD, PhD, Presenter
Basic Science
9:15 AM - 9:30 AM
Nov 15 2024
San Diego, CA

Panel Discussion

Yujin Hoshida, MD, PhD, Moderator
Basic Science
1:58 PM - 1:58 PM
Nov 15 2024
San Diego, CA

Q&A (After each Presentation)

Sumera Ilyas, MD, Moderator
Basic Science

Objectives

  • Identify mechanisms of metabolic rewiring promoting liver cancer development and progression.
  • Describe metabolic competition between tumor cells and metabolic reprogramming of immune cells (immunometabolism).
  • Define the relationship between cancer mutations, metabolic plasticity, and vulnerabilities.
Chair

Davide Povero, PhD, MBA

Mayo Clinic Rochester
Chair

Daniela Sia, PhD

Icahn School of Medicine at Mount Sinai